99 related articles for article (PubMed ID: 7741403)
1. Serum erythropoietin and reticulocyte counts in inflammatory process.
Souweine B; Serre AF; Philippe P; Conio N; Aumaitre O; Marcheix JC
Ann Med Interne (Paris); 1995; 146(1):8-12. PubMed ID: 7741403
[TBL] [Abstract][Full Text] [Related]
2. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
[TBL] [Abstract][Full Text] [Related]
3. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
4. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis.
Fischer R; Simmerlein R; Huber RM; Schiffl H; Lang SM
Pediatr Pulmonol; 2007 Dec; 42(12):1193-7. PubMed ID: 17948283
[TBL] [Abstract][Full Text] [Related]
5. [Pattern of blood levels of erythropoietin and proinflammatory cytokines in patients with anemia of chronic disorders secondary to infection].
Poveda Gómez F; Camacho Siles J; Quevedo Morales E; Fernández Zamorano A; Codoceo Alquinta R; Arnalich Fernández F; Sempere Alcocer M
An Med Interna; 2001 Jun; 18(6):298-304. PubMed ID: 11503575
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow failure following severe injury in humans.
Livingston DH; Anjaria D; Wu J; Hauser CJ; Chang V; Deitch EA; Rameshwar P
Ann Surg; 2003 Nov; 238(5):748-53. PubMed ID: 14578739
[TBL] [Abstract][Full Text] [Related]
7. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
8. Serum erythropoietin and erythroid activity in vitamin B12 deficiency.
Remacha AF; Bellido M; García-Die F; Marco N; Ubeda J; Gimferrer E
Haematologica; 1997; 82(1):67-8. PubMed ID: 9107086
[TBL] [Abstract][Full Text] [Related]
9. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
Marques da Costa R
Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory state and circulating erythropoietin in persons with and without anemia.
Ferrucci L; Guralnik JM; Woodman RC; Bandinelli S; Lauretani F; Corsi AM; Chaves PH; Ershler WB; Longo DL
Am J Med; 2005 Nov; 118(11):1288. PubMed ID: 16271918
[TBL] [Abstract][Full Text] [Related]
11. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary results of erythropoietin treatment of anemia in myelodysplastic syndromes and chronic lymphocytic leukemia].
Gałeza-Obrepalska B; Dwilewicz-Trojaczek J; Paszkowska M; Kuratowska Z
Pol Tyg Lek; 1996 May; 51(19-22):285-8. PubMed ID: 9289712
[TBL] [Abstract][Full Text] [Related]
13. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis.
Acharya VN; Sinha DK; Almeida AF; Pathare AV
J Assoc Physicians India; 1995 Aug; 43(8):539-42. PubMed ID: 8772973
[TBL] [Abstract][Full Text] [Related]
14. Circulating erythropoietin in patients with myelodysplastic syndromes.
Jacobs A; Janowska-Wieczorek A; Caro J; Bowen DT; Lewis T
Br J Haematol; 1989 Sep; 73(1):36-9. PubMed ID: 2803975
[TBL] [Abstract][Full Text] [Related]
15. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.
Artunc F; Risler T
Nephrol Dial Transplant; 2007 Oct; 22(10):2900-8. PubMed ID: 17556407
[TBL] [Abstract][Full Text] [Related]
16. An inappropriate erythropoietic response to iron deficiency anaemia in the elderly.
Matsuo T; Kario K; Kodoma K; Asada R
Clin Lab Haematol; 1995 Dec; 17(4):317-21. PubMed ID: 8697726
[TBL] [Abstract][Full Text] [Related]
17. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well.
Westenbrink BD; Visser FW; Voors AA; Smilde TD; Lipsic E; Navis G; Hillege HL; van Gilst WH; van Veldhuisen DJ
Eur Heart J; 2007 Jan; 28(2):166-71. PubMed ID: 17158825
[TBL] [Abstract][Full Text] [Related]
18. Blunted erythropoietin response to anaemia in rheumatoid arthritis.
Baer AN; Dessypris EN; Goldwasser E; Krantz SB
Br J Haematol; 1987 Aug; 66(4):559-64. PubMed ID: 3663512
[TBL] [Abstract][Full Text] [Related]
19. The effect of subcutaneous recombinant human erythropoietin (r-Hu EPO) in CAPD patients with renal anaemia.
Janicka L; Ksiazek A; Baranowicz I; Mierzicki P
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():67-77. PubMed ID: 8192534
[TBL] [Abstract][Full Text] [Related]
20. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
